A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)

Phase 4CompletedNCT00142558

Organon and Co180 enrolled

Overview

A study to evaluate the effects of etoricoxib and indomethacin in the treatment of acute gout.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

180

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Males or females at least 18 years of age who have acute gout.

Patient assessment of pain (0- to 4- Likert scale)

Patient Global Assessment of Response to Therapy (0- to 4- point scale)

Investigator Global Assessment of Response to Therapy (0- to 4- point scale)

Tenderness of the study joint (0- to 3-point scale)

Swelling of the study joint (0- to 3-point scale)

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.